...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).
【24h】

Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).

机译:CoreValve经导管主动脉瓣植入后永久插入起搏器:发生率和影响因素(英国CoreValve合作组织)。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Permanent pacemaker (PPM) requirement is a recognized complication of transcatheter aortic valve implantation. We assessed the UK incidence of permanent pacing within 30 days of CoreValve implantation and formulated an anatomic and electrophysiological model. METHODS AND RESULTS: Data from 270 patients at 10 centers in the United Kingdom were examined. Twenty-five patients (8%) had preexisting PPMs; 2 patients had incomplete data. The remaining 243 were 81.3+/-6.7 years of age; 50.6% were male. QRS duration increased from 105+/-23 to 135+/-29 milliseconds (P<0.01). Left bundle-branch block incidence was 13% at baseline and 61% after the procedure (P<0.001). Eighty-one patients (33.3%) required a PPM within 30 days. Rates of pacing according to preexisting ECG abnormalities were as follows: right bundle-branch block, 65.2%; left bundle-branch block, 43.75%; normal QRS, 27.6%. Among patients who required PPM implantation, the median time to insertion was 4.0 days (interquartile range, 2.0 to 7.75 days). Multivariable analysis revealed that periprocedural atrioventricular block (odds ratio, 6.29; 95% confidence interval, 3.55 to 11.15), balloon predilatation (odds ratio, 2.68; 95% confidence interval, 2.00 to 3.47), use of the larger (29 mm) CoreValve prosthesis (odds ratio, 2.50; 95% confidence interval, 1.22 to 5.11), interventricular septum diameter (odds ratio, 1.18; 95% confidence interval, 1.10 to 3.06), and prolonged QRS duration (odds ratio, 3.45; 95% confidence interval, 1.61 to 7.40) were independently associated with the need for PPM. CONCLUSION: One third of patients undergoing a CoreValve transcatheter aortic valve implantation procedure require a PPM within 30 days. Periprocedural atrioventricular block, balloon predilatation, use of the larger CoreValve prosthesis, increased interventricular septum diameter and prolonged QRS duration were associated with the need for PPM.
机译:背景:永久性起搏器(PPM)要求是经导管主动脉瓣植入的公认并发症。我们评估了CoreValve植入后30天内英国永久起搏的发生率,并制定了解剖和电生理模型。方法和结果:检查了来自英国10个中心的270名患者的数据。 25例患者(8%)已有PPM。 2例数据不完整。其余的243岁为81.3 +/- 6.7岁;男性占50.6%。 QRS持续时间从105 +/- 23毫秒增加到135 +/- 29毫秒(P <0.01)。左束支传导阻滞发生率在基线时为13%,在手术后为61%(P <0.001)。八十一位患者(33.3%)在30天内需要PPM。根据先前存在的心电图异常,起搏率如下:右束支传导阻滞,占65.2%;左束支传导阻滞,43.75%;正常QRS,27.6%。在需要PPM植入的患者中,插入的中位时间为4.0天(四分位间距为2.0至7.75天)。多变量分析显示,术中房室传导阻滞(比值为6.29; 95%置信区间为3.55至11.15),球囊扩张(比值为2.68; 95%置信区间为2.00至3.47),使用较大的(29 mm)CoreValve假体(比率为2.50; 95%可信区间为1.22至5.11),室间隔直径(比率为1.18; 95%可信区间为1.10至3.06)和QRS持续时间延长(比率为3.45; 95%可信区间) (1.61至7.40)与PPM的需求独立相关。结论:接受CoreValve经导管主动脉瓣植入手术的患者中有三分之一在30天内需要PPM。术中房室传导阻滞,球囊扩张,使用较大的CoreValve假体,增加室间隔直径和延长QRS持续时间与PPM的需要有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号